Overview

A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to: - Assess the relative bioavailability of 2 oral formulations of samatasvir (capsule and tablet prototype test formulation) - Compare the amount of study drug that is in the blood after taking either the capsule form of the drug or the tablet form of the drug while fasting. - Determine the amount of study drug that is in the blood after eating a meal. - Evaluate the safety of the tablet form of samatasvir in healthy people.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.